The impact of age, performance status and comorbidities on nab-paclitaxel plus gemcitabine effectiveness in patients with metastatic pancreatic cancer

Yazar: Martina Catalano, Giuseppe Aprile, Raffaele Conca, Roberto Petrioli, Monica Ramello, Giandomenico Roviello
Baskı/Yayın Bilgisi 2022-05-01

Colonoscopic evaluation of hematochezia in low and average risk patients for colorectal cancer: A prospective study

Yazar: Carlo, Puglisi, Paolo, Russo Francesco, Carmelo, Barbera, Salvatore, Incarbone, Giuseppe, Aprile, Giacomo, Bonanno, Antonio, Russo
Baskı/Yayın Bilgisi 2006

Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma: Myth or Reality?

Yazar: Emanuela Dell’Aquila, Tea Zeppola, Marco Stellato, Francesco Pantano, Mario Scartozzi, Cristina Madaudo, Filippo Pietrantonio, Chiara Cremolini, Giuseppe Aprile, Bruno Vincenzi, Roberto Moretto, Marco Puzzoni, Silvio Ken Garattini, Riccardo Lobefaro, Giuseppe Tonini, Daniele Santini
Baskı/Yayın Bilgisi 2020-08-01

AtezoTRIBE: a randomised phase II study of FOLFOXIRI plus bevacizumab alone or in combination with atezolizumab as initial therapy for patients with unresectable metastatic colorec...

Yazar: Carlotta Antoniotti, Beatrice Borelli, Daniele Rossini, Filippo Pietrantonio, Federica Morano, Lisa Salvatore, Sara Lonardi, Federica Marmorino, Stefano Tamberi, Salvatore Corallo, Giampaolo Tortora, Francesca Bergamo, Di Stefano Brunella, Alessandra Boccaccino, Elisa Grassi, Patrizia Racca, Emiliano Tamburini, Giuseppe Aprile, Roberto Moretto, Luca Boni, Alfredo Falcone, Chiara Cremolini
Baskı/Yayın Bilgisi 2020-07-01